GSK840 (Synonyms: GSK'840) |
| カタログ番号GC34605 |
GSK840 (GSK'840) は、受容体相互作用タンパク質キナーゼ 3 (RIP3 または RIPK3) 阻害剤であり、RIP3 キナーゼ ドメインに 0.9 nM の IC50 で結合し、0.3 nM の IC50 でキナーゼ活性を阻害します 。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2361146-30-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
GSK840 (GSK’840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM[1]. IC50: 0.3 nM (RIP3)[1]
Reference:
[1]. Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56(4):481-95.
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *